bpc-157 fda approval status safety warning to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures – WWLP FDA panel votes to place

Cosmetic composition, comprising in a cosmetically acceptable medium at least one polymeric, ionic compound comprising imidazolium groups (imidazolium compound A), obtainable by reacting a) at least one a-dicarbonyl compound, b) at least one aldehyde, c) at least one amino compound having at least two primary amino groups, d) optionally an amino compound having only one primary amino group and e) at least one protic acid, and optionally subjecting the reaction product to an anion exchange, where the main chain of the at least one compound comprising imidazolium groups does not contain benzene rings, and where in the components a) and b) the aldehyde carbonyl groups may also be present as hemiacetal or acetal and the ketone carbonyl groups may also be present as hemiketal or ketal, at least one associative polymer

The cervical spine in Marfan syndrome

Arch Dis Child

Journal of Investigative Dermatology, 101(1), S143-S147.